Wells Fargo
BBNX

Wells Fargo’s Beta Bionics BBNX Stock Holding History

Wells Fargo’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$216K Sell
21,522
-28,790
-57% -$426K ﹤0.01% 4663
2025
Q4 		$1.53M Buy
50,312
+18,358
+57% +$490K ﹤0.01% 3649
2025
Q3 		$635K Buy
31,954
+16,934
+113% +$298K ﹤0.01% 4125
2025
Q2 		$219K Sell
15,020
-800
-5% -$11.3K ﹤0.01% 4721
2025
Q1 		$194K Buy
+15,820
New +$295K ﹤0.01% 4726

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wells Fargo's BBNX Position: Q1 2026 in Review

Wells Fargo reduced its Beta Bionics (BBNX) stake by 57% in Q1 2026, selling an estimated $426K and leaving 21,522 shares worth $216K. The position accounts for ﹤0.01% of the portfolio, ranked #4663.

Wells Fargo first reported a position in BBNX in Q1 2025 and has held it in 5 quarters since. The position peaked at $1.53M in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Wells Fargo held 21,522 shares of Beta Bionics worth $216K as of Q1 2026.
  • Wells Fargo sold 28,790 Beta Bionics shares in Q1 2026, an estimated $426K.
  • Beta Bionics made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #4663 holding.
  • Wells Fargo first reported a position in Beta Bionics in Q1 2025 and has held it in 5 quarters since.
  • Wells Fargo's Beta Bionics position peaked at $1.53M in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.